Our results are comparable with those of Levicar et al. [14], who showed absence of any focal lesions in five patients treated by stem cell therapy who were followed-up by CT scan and serum AFP for 18 months, indicating that the stem cell product used was safe in the short term and over the long term, by absence of tumour formation. This evidence concerns the gene AFP and neoplasm.